Rafferty Asset Management
MDCO

Rafferty Asset Management’s Medicines Co MDCO Stock Holding History

Rafferty Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-46,584
Closed -$3.96M – 895
2019
Q4 		$3.96M Sell
46,584
-89,146
-66% -$5.94M 0.06% 166
2019
Q3 		$6.79M Sell
135,730
-6,249
-4% -$249K 0.11% 109
2019
Q2 		$5.18M Buy
+141,979
New +$4.63M 0.09% 157

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Rafferty Asset Management's MDCO Position: Q1 2020 in Review

Rafferty Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 46,584 shares — an estimated $3.96M sold.

Rafferty Asset Management first reported a position in MDCO in Q2 2019 and held it in 3 quarters. The position peaked at $6.79M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Rafferty Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Rafferty Asset Management sold 46,584 Medicines Co shares in Q1 2020, an estimated $3.96M.
  • Rafferty Asset Management first reported a position in Medicines Co in Q2 2019 and held it in 3 quarters.
  • Rafferty Asset Management's Medicines Co position peaked at $6.79M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Rafferty Asset Management's 13F filing for Q1 2020, filed 15 May 2020.